💊 의약품 A-Z 🧬 표적 🛠 도구 📚 가이드
전체 의약품 약물 분류 치료 영역 부작용
가이드 용어집 연대표
비교 약물 체내 여정 약물 계열
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Theophylline

CHEMBL1355736 Phase 4 승인됨 Protein
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
180.2 g/mol
LogP
—
Phase
4

This bronchodilator medication relaxes and opens the airways in the lungs, making it easier to breathe in conditions like asthma and chronic obstructive pulmonary disease (COPD). It has a narrow therapeutic window, meaning the difference between an effective and a toxic dose is small, so blood levels must be monitored regularly. It can be affected by many foods, medications, and smoking.

분자량

180.1600 g/mol

LogP

0.00

TPSA

69.30 Ų

리핀스키 5의 법칙

통과

치료 영역

Bladder Cancer Glaucoma Non-Small Cell Lung Cancer Asthma Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Hypertension Major Depressive Disorder Breast Cancer Gout Atrial Fibrillation Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
Cn1c(=O)c2nc[nH]c2n(C)c1=O.O

                

                

                
                

                    
InChI

                    
InChI=1S/C7H8N4O2.H2O/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;/h3H,1-2H3,(H,8,9);1H2

                

                

                

                    
                    

                        
Molecular Formula

                        
C7H8N4O2

                    

                    
                    

                        
HBD / HBA

                        
1 / 3

                    

                    
                    

                        
회전 가능 결합

                        
0

                    

                    
                    
                    

                        
무거운 원자

                        
13

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
자주 묻는 질문

                

                    
                    

                        
                        

                            
This bronchodilator medication relaxes and opens the airways in the lungs, making it easier to breathe in conditions like asthma and chronic obstructive pulmonary disease (COPD). It has a narrow therapeutic window, meaning the difference between an effective and a toxic dose is small, so blood levels must be monitored regularly. It can be affected by many foods, medications, and smoking.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Theophylline is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1355736.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 2153.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
의학적 면책조항

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.